Drug Used to Treat COVID-Related Loss of Smell Found Ineffective: Study

Contact Your Elected Officials

Clinical trial results were manipulated by the manufacturer to exaggerate the drug’s effectiveness, especially for off-label use.

For many COVID-19 survivors, the inability to smell life’s aromas is an unseen affliction that lasts months after recovering from the infection. This hidden impairment robs them of a primal sense, leaving them disconnected.

Hope emerged when doctors prescribed gabapentin to treat COVID-related smell loss. But new research has deflated expectations, finding in a double-blinded, placebo-controlled clinical trial that the medication is ineffective.

Gabapentin Falls Short in 8-Week Trial

The trial ran from January 2022 to February 2023, involving adults with at least three months of smell dysfunction after COVID-19 infection. Those with other causes for smell disorders or inability to take gabapentin were excluded.

Researchers enrolled 68 participants, randomly assigning 34 to a placebo group and 34 to an oral gabapentin treatment group. All patients were exposed to the maximum tolerable dose for four weeks. After that, doses were adjusted to the highest tolerable amount, maintained during an eight-week fixed-dose phase. In the gabapentin group, 56 percent received the maximum dose of 3,600 milligrams daily.

After completing that phase, 41 participants were tapered off and monitored for four more weeks.

The researchers found no clinically meaningful difference between the gabapentin and placebo groups over the entire duration of the trial.

“Changes in subjective olfactory function, objective odor identification, and olfactory-related quality of life were neither clinically meaningful nor statistically significant,” the trial researchers wrote.

However, the authors noted that the findings applied only to an eight-week treatment period. Longer treatment may yield different results.

Side Effects

The most common adverse effects were fatigue, reported by 10 in the gabapentin group and 11 in the placebo group, along with expected side effects like dizziness, weight gain, and brain fog in the gabapentin group.

No serious adverse events occurred in either group.

By George Citroner

Read Full Article on TheEpochTimes.com

The Epoch Times
The Epoch Timeshttps://www.theepochtimes.com/
Tired of biased news? The Epoch Times is truthful, factual news that other media outlets don't report. No spin. No agenda. Just honest journalism like it used to be.

Hamas’s Stubborn Grip on Arms Signals No Desire for Genuine Peace

Hamas’s rhetoric reflects its founding ideology, prioritizing armed resistance over civilian welfare or diplomatic progress.

Off the radar

In the longstanding and brutal ledger of religious persecution, Nigeria now occupies its own grim chapter with its enduring pogrom against Christians.

The New Jackboots? A Wake-Up Call on Antifa and Fascism

An analysis of whether Antifa truly opposes fascism by comparing its tactics and behavior to historical signs and movements of fascist regimes.

If Federal Food Assistance Programs End, Theft Begins

Many patriotic Americans well versed in American History have...

Tucker EN FUEGO: Taking Stock of MAGA, Ten Years on

Draining of the Swamp has yet to come anything close to fruition, as the creatures that populate said Swamp yet cling bitterly to power.

Dallas Doctor Surrenders License After Texas AG Sues for Prescribing Gender Transition Drugs to Minors

Doctor surrendered her medical license following lawsuit by Texas AG Paxton, accusing her of illegally prescribing gender transition drugs to minors.

June Lockhart, Beloved Mother Figure From ‘Lassie’ and ‘Lost in Space,’ Dies at 100

June Lockhart, a mother figure for a generation of TV viewers whether at home in “Lassie” or in the stratosphere in “Lost in Space,” has died at 100.

Kamala Harris Teases New White House Run: ‘I Am Not Done’

Kamala Harris hinted in a BBC interview that she may run for president again in 2028, saying she hasn’t ruled out another White House bid.

TCM Classic Tour at Warner Bros. Studio: Finding Stardust in Today’s Hollywood

Warner Bros. launched the TCM Classic Films Tour in April 2024, offering visitors a nostalgic journey through the studio’s historic movie legacy.

Trump Hikes Canada’s Tariffs by 10 Percent for Not Pulling Anti-Tariff Ad Immediately

Trump announced he will increase tariffs on Canada by 10% after ad by provincial government of Ontario misrepresented President Reagan’s speech on tariffs.

Trump Rolls Back Emissions Rules on Copper Smelters

President Trump issued a proclamation aimed at reversing a Biden-era environmental rule that enforced stricter air emission standards on copper smelters.

Donor Gives $130 Million to Cover Shortfall in Troop Pay During Shutdown

Trump announced on Oct. 23 that an anonymous donor sent $130M to cover military pay during the ongoing government shutdown.

‘Frustration’ With Canada Led to Trump Scrapping Talks, Not Just Ontario’s Ad: US Official

President Trump cited Ontario’s TV ad as the reason for halting Canada trade talks, but officials say it stems from rising U.S. frustration with Ottawa.
spot_img

Related Articles

Popular Categories

MAGA Business Central